While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Last month, OpenAI announced that its latest version of ChatGPT had solved a major math problem, one that had stumped experts ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

We’ve been discussing simplifying protocol designs for decades. And yet, a phase III protocol today collects nearly 6 million data points on average; a figure that’s been climbing by roughly 11% ...

As the school year winds down, a familiar concern starts to creep in: What happens to all that screen time during summer? I read this all the time: “I know they're getting too much screen time…” Or a ...

Terraform scales beautifully — until it doesn't. Explore the real challenges engineering teams face with Terraform at scale and the AI-assisted solutions reshaping IaC management. Terraform promised ...

Time travel is one of the most fascinating ideas in science. The ability to go back, change events, or see the future sounds almost limitless. But the moment you actually think about it… things start ...

Early problems with language can have a lasting negative impact on social and emotional development. Building on this foundation, a new groundbreaking study from Florida Atlantic University and Aarhus ...

When a startup struggles, founders usually assume the solution is obvious: more marketing, more hiring, or more capital. But in my experience advising founders, the real issue is usually something ...

Executives are increasingly enamored with the promise of an AI-driven transformation and have invested accordingly. Most large-scale companies have initiated hundreds of pilots and provided widespread ...

In a recent touch base with a former client, let’s call him Ed, he opened our call by boasting about how “crazy busy” he was. He arrived a few minutes late, emphatically blaming a previous team ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...